If You Suffered Losses on Your DexCom, Inc. Investment, Contact BFA Law before October 21 about Class Action Lawsuit ...

Medical device maker DexCom (DXCM) operates in a highly competitive market for continuous glucose monitoring (CGM) systems, ...

The healthcare stock is in a tailspin, trading down more than 50% from its high after a steep sell-off following its latest ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...

The Apple Watch integration with the Dexcom G7 continuous glucose monitor (CGM) has revolutionized diabetes management. With the best Apple Watch models, users can view real-time blood sugar data ...

Maintaining stable glucose levels is essential for your overall health, whether or not you have diabetes. Here's ...

Sanctuary Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the second ...

Labaton Keller Sucharow LLP (“Labaton”) announces that, on October 8, 2024, it filed a securities class action lawsuit (the ...

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

Lithuania has proven to be an excellent fit for Dexcom due to its strong business environment, skilled workforce, and ...

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

DexCom has helped revolutionize diabetes care with continuous glucose monitoring (CGM) devices. Patients wear a patch that continuously transmits blood sugar data to a device or smartphone.